We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.15 | -2.05% | 7.15 | 6.80 | 7.50 | 7.30 | 7.15 | 7.15 | 159,594 | 08:40:29 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.01 | 42.92M |
From Apr 2019 to Apr 2024
TIDMKMK
RNS Number : 5512B
Kromek Group PLC
11 January 2018
11 January 2018
Kromek Group plc
("Kromek" or the "Company")
Appointment of Joint Broker
Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, is pleased to announce the immediate appointment of Cantor Fitzgerald Europe as Joint Broker to the Company. Cenkos Securities will remain as Nominated Adviser and Joint Broker to the Company.
For further information, please contact:
Kromek Group plc Arnab Basu, CEO +44 (0)1740 Derek Bulmer, CFO 626 060 Cenkos Securities plc (Nominated Adviser and Joint Broker) Bobbie Hilliam (NOMAD) +44 (0)20 7397 Julian Morse (Sales) 8900 Cantor Fitzgerald Europe (Joint Broker) Philip Davies +44 (0)20 7894 Will Goode 7000 Luther Pendragon Ltd (PR) Harry Chathli Claire Norbury +44 (0)20 7618 Alexis Gore 9100
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFUEFSFASEEF
(END) Dow Jones Newswires
January 11, 2018 02:00 ET (07:00 GMT)
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
